NYSE - Delayed Quote USD

Perrigo Company plc (PRGO)

Compare

24.38

-0.67

(-2.67%)

At close: January 10 at 4:00:02 PM EST

24.40

+0.02

+(0.08%)

After hours: January 10 at 6:17:49 PM EST

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer

Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced the expansion of its Chief Scientific Office by uniting and integrating all global quality, pharmacovigilance, patient safety, regulatory affairs and innovation teams, enhancing organizational agility and scale. This expansion also further supports the Company's consumer-led innovation pipeline.

PR Newswire 6 days ago

PRGO
-2.67%
Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?

Perrigo (PRGO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks last month

PRGO
-2.67%
ZBH
Perrigo (PRGO) International Revenue Performance Explored

Review Perrigo's (PRGO) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

Zacks 2 months ago

PRGO
-2.67%
^GSPC
Perrigo Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.11 profit in 3Q 2023)

Perrigo ( NYSE:PRGO ) Third Quarter 2024 Results Key Financial Results Revenue: US$1.09b (down 3.2% from 3Q 2023). Net...

Simply Wall St. 2 months ago

PRGO
-2.67%
Perrigo (NYSE:PRGO) Is Paying Out A Dividend Of $0.276

Perrigo Company plc ( NYSE:PRGO ) has announced that it will pay a dividend of $0.276 per share on the 17th of...

Simply Wall St. 2 months ago

PRGO
-2.67%
Perrigo Co PLC (PRGO) Q3 2024 Earnings Call Highlights: Strategic Savings and EPS Growth Amid ...

Perrigo Co PLC (PRGO) reports a 26.6% increase in EPS and significant savings through Project Energize, despite a 3.2% drop in net sales.

GuruFocus.com 2 months ago

PRGO
-2.67%
Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated

PRGO reports weaker-than-expected third-quarter 2024 results. Though management updates top-line guidance for 2024, it reaffirms the bottom-line outlook.

Zacks 2 months ago

PRGO
-2.67%
BIIB
/C O R R E C T I O N -- Perrigo Company plc/

Third Quarter 2024 Highlights:

PR Newswire 2 months ago

PRGO
-2.67%
Perrigo (PRGO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks 2 months ago

PRGO
-2.67%
Perrigo (PRGO) Q3 Earnings and Revenues Lag Estimates

Perrigo (PRGO) delivered earnings and revenue surprises of -1.22% and 2.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

PRGO
-2.67%
WRBY
Perrigo: Q3 Earnings Snapshot

DUBLIN (AP) — Perrigo Co. (PRGO) on Wednesday reported a loss of $21 million in its third quarter. The Dublin-based company said it had a loss of 15 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were 81 cents per share.

Associated Press Finance 2 months ago

PRGO
-2.67%
Perrigo to Report Q3 Earnings: Here's What to Expect

PRGO's Q3 top line is expected to have been affected by lower net product sales in the United States and unfavorable currency movements in the quarter.

Zacks 2 months ago

PRGO
-2.67%
Perrigo Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.276 per share, payable on December 17, 2024, to shareholders of record on November 29, 2024.

PR Newswire 2 months ago

PRGO
-2.67%
Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for

QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 2 months ago

PRGO
-2.67%
Perrigo (PRGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks 2 months ago

PRGO
-2.67%
Perrigo Company plc (PRGO): Leading OTC Health Products with Strong Growth in Infant Formula

We recently published a list of 10 Best Depressed Stocks To Buy Heading into 2025. In this article, we are going to take a look at where Perrigo Company plc (NYSE:PRGO) stands against other best depressed stocks to buy heading into 2025. Will a Strong Earnings Season Help Overcome Election Volatility? In one of our […]

Insider Monkey 2 months ago

PRGO
-2.67%
Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2024 financial results on Wednesday, November 6, 2024, and host a conference call beginning at 8:30 A.M. (EST).

PR Newswire 2 months ago

PRGO
-2.67%
WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health

Today, Opill®—the first and only daily birth control pill available without a prescription in the U.S.—announces the launch of its partnership with WNBA Star and two-time Olympic Gold Medalist Napheesa Collier. The collaboration builds on Opill's multi-year partnership with the Women's National Basketball Association (WNBA).

PR Newswire 2 months ago

PRGO
-2.67%
Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio

Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, today announced a new brand partnership: Good Start®1 and Dr. Brown's®2 infant formula solutions. Good Start®, a trusted infant formula brand for over 50 years, and Dr. Brown's®, makers of the No. 1 pediatrician-recommended baby bottle in the U.S.3, share a long-time mission of creating confident feeding experiences for families.

PR Newswire 3 months ago

PRGO
-2.67%
PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY

Perrigo Company plc ("Perrigo" or the "Company") (NYSE: PRGO) today announced the closing of a registered public offering by Perrigo Finance Unlimited Company, an indirect wholly-owned finance subsidiary of Perrigo (the "Issuer"), of $715 million aggregate principal amount of the Issuer's 6.125% Senior Notes due 2032 (the "USD Notes") and €350 million aggregate principal amount of the Issuer's 5.375% Senior Notes due 2032 (the "Euro Notes" and together with the USD Notes, the "Notes"). The Notes

PR Newswire 3 months ago

PRGO
-2.67%

Performance Overview

Return	PRGO	S&P 500
YTD	-3.60%	-1.35%
1-Year	-25.86%	+22.51%
3-Year	-34.41%	+24.59%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Perrigo Company plc (PRGO)

Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer

Perrigo (PRGO) Up 5.6% Since Last Earnings Report: Can It Continue?

Perrigo (PRGO) International Revenue Performance Explored

Perrigo Third Quarter 2024 Earnings: US$0.13 loss per share (vs US$0.11 profit in 3Q 2023)

Perrigo (NYSE:PRGO) Is Paying Out A Dividend Of $0.276

Perrigo Co PLC (PRGO) Q3 2024 Earnings Call Highlights: Strategic Savings and EPS Growth Amid ...

Perrigo's Q3 Earnings Fall Short of Estimates, Sales View Updated

/C O R R E C T I O N -- Perrigo Company plc/

Perrigo (PRGO) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Perrigo (PRGO) Q3 Earnings and Revenues Lag Estimates

Perrigo: Q3 Earnings Snapshot

Perrigo to Report Q3 Earnings: Here's What to Expect

Perrigo Announces Quarterly Dividend

Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for

Perrigo (PRGO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Perrigo Company plc (PRGO): Leading OTC Health Products with Strong Growth in Infant Formula

Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024

WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health

Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio

PERRIGO ANNOUNCES THE CLOSING OF A SENIOR NOTES OFFERING BY ITS FINANCE SUBSIDIARY, PERRIGO FINANCE UNLIMITED COMPANY

Performance Overview